secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2023-11-22T23:59:59+00:00
Accession:  0001493152-23-042506
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences receives Nasdaq deficiency notice for failing to meet minimum stockholders' equity requirement
--------------------------------------------------------------------------------

- Stockholders' equity reported $2,435,646 as of Sept 30, 2023, below $2,500,000 minimum.
- Company has until Jan 5, 2024 to submit a plan to regain compliance to Nasdaq.
- If plan accepted, Nasdaq may grant up to 180-day extension to regain compliance.
- Company does not meet alternative quantitative standards for continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315223042506/0001493152-23-042506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315223042506/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-042506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer